251 related articles for article (PubMed ID: 20423984)
1. New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK.
Zadra G; Priolo C; Patnaik A; Loda M
Clin Cancer Res; 2010 Jul; 16(13):3322-8. PubMed ID: 20423984
[TBL] [Abstract][Full Text] [Related]
2. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase and cancer.
Wang W; Guan KL
Acta Physiol (Oxf); 2009 May; 196(1):55-63. PubMed ID: 19243571
[TBL] [Abstract][Full Text] [Related]
4. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
Popovics P; Frigo DE; Schally AV; Rick FG
Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
[TBL] [Abstract][Full Text] [Related]
5. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
Zadra G; Photopoulos C; Tyekucheva S; Heidari P; Weng QP; Fedele G; Liu H; Scaglia N; Priolo C; Sicinska E; Mahmood U; Signoretti S; Birnberg N; Loda M
EMBO Mol Med; 2014 Apr; 6(4):519-38. PubMed ID: 24497570
[TBL] [Abstract][Full Text] [Related]
6. Metabolic alterations and targeted therapies in prostate cancer.
Flavin R; Zadra G; Loda M
J Pathol; 2011 Jan; 223(2):283-94. PubMed ID: 21125681
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
[TBL] [Abstract][Full Text] [Related]
8. Metabolic regulation of neuronal plasticity by the energy sensor AMPK.
Potter WB; O'Riordan KJ; Barnett D; Osting SM; Wagoner M; Burger C; Roopra A
PLoS One; 2010 Feb; 5(2):e8996. PubMed ID: 20126541
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.
Li H; Thali RF; Smolak C; Gong F; Alzamora R; Wallimann T; Scholz R; Pastor-Soler NM; Neumann D; Hallows KR
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F167-77. PubMed ID: 20462973
[TBL] [Abstract][Full Text] [Related]
10. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
[TBL] [Abstract][Full Text] [Related]
11. AMPK activation protects against prostate cancer by inducing a catabolic cellular state.
Penfold L; Woods A; Pollard AE; Arizanova J; Pascual-Navarro E; Muckett PJ; Dore MH; Montoya A; Whilding C; Fets L; Mokochinski J; Constantin TA; Varela-Carver A; Leach DA; Bevan CL; Nikitin AY; Hall Z; Carling D
Cell Rep; 2023 Apr; 42(4):112396. PubMed ID: 37061917
[TBL] [Abstract][Full Text] [Related]
12. Salicylate enhances the response of prostate cancer to radiotherapy.
Broadfield LA; Marcinko K; Tsakiridis E; Zacharidis PG; Villani L; Lally JSV; Menjolian G; Maharaj D; Mathurin T; Smoke M; Farrell T; Muti P; Steinberg GR; Tsakiridis T
Prostate; 2019 Apr; 79(5):489-497. PubMed ID: 30609074
[TBL] [Abstract][Full Text] [Related]
13. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
14. Cross-talk between AMPK and mTOR in regulating energy balance.
Xu J; Ji J; Yan XH
Crit Rev Food Sci Nutr; 2012; 52(5):373-81. PubMed ID: 22369257
[TBL] [Abstract][Full Text] [Related]
15. Role of AMPK and its molecular intermediates in subjugating cancer survival mechanism.
Thirupathi A; Chang YZ
Life Sci; 2019 Jun; 227():30-38. PubMed ID: 31002918
[TBL] [Abstract][Full Text] [Related]
16. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
Guo D; Hildebrandt IJ; Prins RM; Soto H; Mazzotta MM; Dang J; Czernin J; Shyy JY; Watson AD; Phelps M; Radu CG; Cloughesy TF; Mischel PS
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12932-7. PubMed ID: 19625624
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells.
Galdieri L; Gatla H; Vancurova I; Vancura A
J Biol Chem; 2016 Nov; 291(48):25154-25166. PubMed ID: 27733682
[TBL] [Abstract][Full Text] [Related]
18. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
19. AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy.
Schiewer MJ; Knudsen KE
EMBO Mol Med; 2014 Apr; 6(4):439-41. PubMed ID: 24562461
[TBL] [Abstract][Full Text] [Related]
20. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
Krishan S; Richardson DR; Sahni S
Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
